Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention: a Multicenter, Randomized Controlled Trial

NCT06626126 is registered in ClinicalTrials.gov with University Medical Center Ho Chi Minh City (UMC) as lead sponsor.

NCT NCT06626126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06626126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention: a Multicenter, Randomized Controlled Trial
Lead sponsor
University Medical Center Ho Chi Minh City (UMC)
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
January 1, 2029
Enrollment
1,448 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad), ldl-cholesterol, lipid metabolism disorders, percutaneous coronary intervention